Antitumor activity of imexon.
Sagaster
P
P
Kokoschka
E M
EM
Kokron
O
O
Micksche
M
M
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006588:Hexanones / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D006588:Hexanones; D007155:Immunologic Factors; C014919:4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one